Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,350.16 87.60 0.54%
S&P 500 1,851.07 8.09 0.44%
NASDAQ 4,057.83 23.67 0.59%
Ticker Volume Price Price Delta
STOXX 50 3,122.55 31.03 1.00%
FTSE 100 6,571.19 29.58 0.45%
DAX 9,260.36 86.65 0.94%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

Horizon Pharma to Present at the 25th Annual ROTH Conference


Horizon Pharma to Present at the 25th Annual ROTH Conference

DEERFIELD, IL -- (Marketwire) -- 03/11/13 -- Horizon Pharma, Inc. (NASDAQ: HZNP), today announced that Timothy P. Walbert, chairman, president and chief executive officer will present at the 25th Annual ROTH Conference on Monday, March 18th at 8:30a.m. Pacific Time in Laguna Nigel, CA. Mr. Walbert will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for 10 business days.

About Horizon Pharma Horizon Pharma, Inc. is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire, in-license and/or co-promote additional innovative medicines where it can execute a targeted commercial approach in specific therapeutic areas while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit www.horizonpharma.com.

Contacts Robert J. De Vaere Executive Vice President and Chief Financial Officer investor-relations@horizonpharma.com

Investors Kathy Galante Burns McClellan, Inc. 212-213-0006 kgalante@burnsmc.com

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement